BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang J, Pan C, Sun P, Feng E, Wu J, Zhu L, Wang H. Application of an O-Linked Glycosylation System in Yersinia enterocolitica Serotype O:9 to Generate a New Candidate Vaccine against Brucella abortus. Microorganisms 2020;8:E436. [PMID: 32244903 DOI: 10.3390/microorganisms8030436] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Heidary M, Dashtbin S, Ghanavati R, Mahdizade Ari M, Bostanghadiri N, Darbandi A, Navidifar T, Talebi M. Evaluation of Brucellosis Vaccines: A Comprehensive Review. Front Vet Sci 2022;9:925773. [DOI: 10.3389/fvets.2022.925773] [Reference Citation Analysis]
2 Sun P, Li X, Pan C, Liu Z, Wu J, Wang H, Zhu L. A Short Peptide of Autotransporter Ata Is a Promising Protective Antigen for Vaccination Against Acinetobacter baumannii. Front Immunol 2022;13:884555. [DOI: 10.3389/fimmu.2022.884555] [Reference Citation Analysis]
3 Shi Y, Pan C, Wang K, Liu Y, Sun Y, Guo Y, Sun P, Wu J, Lu Y, Zhu L, Wang H. Construction of Orthogonal Modular Proteinaceous Nanovaccine Delivery Vectors Based on mSA-Biotin Binding. Nanomaterials (Basel) 2022;12:734. [PMID: 35269221 DOI: 10.3390/nano12050734] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 He C, Yang J, Zhao H, Liu M, Wu D, Liu B, He S, Chen Z. Vaccination with a Brucella ghost developed through a double inactivation strategy provides protection in Guinea pigs and cattle. Microb Pathog 2021;162:105363. [PMID: 34919994 DOI: 10.1016/j.micpath.2021.105363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Cao Z, Lin S, Liu J. Bacteria-Based Microdevices for the Oral Delivery of Macromolecules. Pharmaceutics 2021;13:1610. [PMID: 34683903 DOI: 10.3390/pharmaceutics13101610] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Mauri M, Sannasiddappa TH, Vohra P, Corona-Torres R, Smith AA, Chintoan-Uta C, Bremner A, Terra VS, Abouelhadid S, Stevens MP, Grant AJ, Cuccui J, Wren BW; Glycoengineering of Veterinary Vaccines Consortium. Multivalent poultry vaccine development using Protein Glycan Coupling Technology. Microb Cell Fact 2021;20:193. [PMID: 34600535 DOI: 10.1186/s12934-021-01682-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
7 Pan C, Yue H, Zhu L, Ma GH, Wang HL. Prophylactic vaccine delivery systems against epidemic infectious diseases. Adv Drug Deliv Rev 2021;176:113867. [PMID: 34280513 DOI: 10.1016/j.addr.2021.113867] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
8 Peng Z, Wu J, Wang K, Li X, Sun P, Zhang L, Huang J, Liu Y, Hua X, Yu Y, Pan C, Wang H, Zhu L. Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host. Adv Sci (Weinh) 2021;8:e2100549. [PMID: 34032027 DOI: 10.1002/advs.202100549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
9 Zai X, Yin Y, Guo F, Yang Q, Li R, Li Y, Zhang J, Xu J, Chen W. Screening of potential vaccine candidates against pathogenic Brucella spp. using compositive reverse vaccinology. Vet Res 2021;52:75. [PMID: 34078437 DOI: 10.1186/s13567-021-00939-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xu H, Huang J, Liu Z, Li X, Wang K, Feng E, Wu J, Zhu L, Yao K, Pan C, Wang H. Expression of Bordetella pertussis Antigens Fused to Different Vectors and Their Effectiveness as Vaccines. Vaccines (Basel) 2021;9:542. [PMID: 34064136 DOI: 10.3390/vaccines9060542] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dow JM, Mauri M, Scott TA, Wren BW. Improving protein glycan coupling technology (PGCT) for glycoconjugate vaccine production. Expert Review of Vaccines 2020;19:507-27. [DOI: 10.1080/14760584.2020.1775077] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]